Corrigendum: Systematic benchmarking of nanopore Q20+ kit in SARS-CoV-2 whole genome sequencing
Junhong Luo(Nanjing Medical University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Zixinrong Meng(Nanjing Medical University), Xiaojuan Zhu(University of Tennessee at Knoxville), Lei Wang(Guangzhou University of Chinese Medicine), Qiao Qiao(First Hospital of China Medical University), Xingyu Xu, Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Ling‐Feng Mao
Cited by 2
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204